Characterization & evaluation of novel CYP2A4 inhibitors as anti-proliferative/prodifferentiating agents targeted towards hormone refractory prostate cancer

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date1/07/08 → 31/07/09